tiprankstipranks
Astria Therapeutics, Inc. (ATXS) Q4 Earnings Cheat Sheet
PremiumPre-EarningsAstria Therapeutics, Inc. (ATXS) Q4 Earnings Cheat Sheet
8d ago
Promising Trial Results and Growth Potential Justify Buy Rating for Astria Therapeutics
Premium
Ratings
Promising Trial Results and Growth Potential Justify Buy Rating for Astria Therapeutics
10d ago
Astria initiates ALPHA-ORBIT Phase 3 trial of navenibart for HAE treatment
Premium
The Fly
Astria initiates ALPHA-ORBIT Phase 3 trial of navenibart for HAE treatment
13d ago
Astria Therapeutics Unveils Phase 3 Trial for Navenibart
PremiumCompany AnnouncementsAstria Therapeutics Unveils Phase 3 Trial for Navenibart
2M ago
Astria Therapeutics Expands Stock Incentive Plan
Premium
Company Announcements
Astria Therapeutics Expands Stock Incentive Plan
3M ago
Astria Therapeutics price target raised to $32 from $28 at Oppenheimer
Premium
The Fly
Astria Therapeutics price target raised to $32 from $28 at Oppenheimer
3M ago
Astria Therapeutics reports Q3 EPS (42c), consensus (42c)
PremiumThe FlyAstria Therapeutics reports Q3 EPS (42c), consensus (42c)
4M ago
Is ATXS a Buy, Before Earnings?
Premium
Pre-Earnings
Is ATXS a Buy, Before Earnings?
4M ago
EC grants Astria’s OMPD to navenibart for HAE
Premium
The Fly
EC grants Astria’s OMPD to navenibart for HAE
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100